N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide
C21H24ClN3O3S2 — CID 122175631
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide
N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide (PubChem CID 122175631) has the molecular formula C21H24ClN3O3S2 and a molecular weight of 466.03 g/mol. Its IUPAC name is N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide.
Molecular Properties
| Compound Name | N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide |
|---|---|
| PubChem CID | 122175631 |
| Molecular Formula | C21H24ClN3O3S2 |
| Molecular Weight | 466.03 g/mol |
| Exact Mass | 465.09 |
| IUPAC Name | N-(3-chloro-2-methylphenyl)-4-methyl-2-[(2-methyl-1,3-benzothiazol-6-yl)sulfonylamino]pentanamide |
| SMILES | Cc1nc2ccc(S(=O)(=O)NC(CC(C)C)C(=O)Nc3cccc(Cl)c3C)cc2s1 |
| InChI | InChI=1S/C21H24ClN3O3S2/c1-12(2)10-19(21(26)24-17-7-5-6-16(22)13(17)3)25-30(27,28)15-8-9-18-20(11-15)29-14(4)23-18/h5-9,11-12,19,25H,10H2,1-4H3,(H,24,26) |
| InChIKey | FGAWANKETLFLGC-UHFFFAOYSA-N |
| XLogP | 4.90 |
| TPSA | 88.16 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.03 |
| LogP ≤ 5 | 4.90 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122175631 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.